INSIGHTS ON DRUG DEVELOPMENT
-
A Simple And Powerful Solution For Accelerating Dissolution
Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form
Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.
-
Native SEC-MALS Characterization Using A Chromatography Data System
Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.
-
A Timeline Of U.S. Actions To Reduce Animal Models In Research
Policy and scientific validation have aligned to shift drug development beyond animal models. New regulations and technologies are making human‑relevant methods the standard for preclinical research.
-
Navigating The Development Of Dry Powder For Inhalation9/9/2026
A CDMO-authored framework for navigating dry powder inhaler development, covering target product profile definition, API characterization, particle engineering technology selection, and encapsulation considerations.
-
Label-Free Analysis Of Multiple Spheroids In A Matrix11/7/2025
Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
-
How The Accelerator™ Drug Development Model Enhances eNPV2/25/2026
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Validation Provider Shortens The Path To Equipment Qualification8/19/2025
Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.
DRUG DEVELOPMENT SOLUTIONS
-
Your Method Development Toolbox
ACD/Method Selection Suite is your software assistant for LC and GC method development. When you want to develop methods using Quality by Design (QbD) principles, and make every experiment count, reach for Method Selection Suite to:
- Choose your starting conditions and columns
- Simulate separations under new conditions
- Optimize your chromatography with 1D, 2D, or 3D models
- Predict the retention times of new compounds
- Database successful methods for future use
-
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
-
Leica M125 C Encoded Stereo Microscopes
Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
- Coded microscopes consistently deliver calibrated and comparable images
- Reproduce images in moments with the Leica “Store and Recall” function
- Fully apochromatic corrected zoom optics deliver high quality images
- Customize the microscope system to your task with the exclusive range of accessories
-
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
Explore an expansion service with experts that will work closely with you to customize your process and meet your unique needs by adjusting protocols, optimizing conditions, and providing personalized support.